MYCN is a transcription factor whose target genes are widely involved in metabolism, apoptosis, and cell growth (5–7), and its dysregulation in neuroblastoma leads to increased proliferation, decreased apoptosis, and differentiation arrest (8, 9). This evidence concerns the gene MYCN and neuroblastoma.